Drospirenone
Generic Details
Generic Name
Drospirenone
Other Names
- DRSP
Drug Class
- Progestin
Chemical Formula
C24H30O3
Molecular Weight
366.49 g/mol
Mechanism of Action
- Antiandrogenic and antimineralocorticoid properties
- Progestogenic activity
Indications
- Oral contraceptive
- Treatment of premenstrual dysphoric disorder (PMDD)
- Treatment of moderate acne in women seeking contraception
Common Dosage Forms
- Oral tablets
Typical Dosage
- 3 mg once daily for 21 days, followed by 7 days without drug
Pediatric Dosage
Geriatric Dosage
Side Effects
- Nausea
- Headache
- Breast pain
- Irregular vaginal bleeding
- Mood changes
Contraindications
- Hypersensitivity to drospirenone or any component of the formulation
- Thromboembolic disorders
- Liver disease
Pregnancy Category
- X - Contraindicated
Lactation Safety
- Limited data available, caution advised
Drug Interactions
- Potentially increases potassium levels; avoid concomitant use with potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers, NSAIDs
Overdose Symptoms
- Nausea
- Vomiting
- Bleeding
Antidote for Overdose
- No specific antidote, manage symptoms and provide supportive care
Storage Conditions
- Store at room temperature away from moisture and heat
Pharmacokinetics
- Absorption: Well absorbed from the gastrointestinal tract
- Distribution: High plasma protein binding
- Metabolism: Extensive hepatic metabolism
- Excretion: Mainly renal excretion
Precautions
- Monitor potassium levels periodically especially in patients at risk for hyperkalemia
Warnings
- Increased risk of venous thromboembolism
- Increased risk of hyperkalemia, particularly in patients with renal insufficiency or on concomitant medications that increase potassium levels
Others
- Drospirenone is a synthetic progestin with spironolactone-like properties.